Logo for Jaguar Health Inc

Jaguar Health Investor Relations Material

Latest events

Logo for Jaguar Health Inc

Q1 2024

Jaguar Health
Logo for Jaguar Health

Q1 2024

14 May, 2024
Logo for Jaguar Health

Q4 2023

1 Apr, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Jaguar Health Inc

Access all reports
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company has a lead product candidate Mytesi, which is commercialized in the United States for the prevention of hemorrhagic cystitis in patients with cancer receiving certain types of chemotherapy; for the treatment of Noninfectious Diarrhea in adult patients living with HIV/AIDS receiving antiretroviral therapy; and for reduction of severity, frequency and duration of diarrhea.